The Pennant Group, Inc. (PNTG)
- Previous Close
29.41 - Open
29.36 - Bid 30.14 x 100
- Ask 30.35 x 100
- Day's Range
28.89 - 30.27 - 52 Week Range
21.18 - 37.13 - Volume
194,189 - Avg. Volume
219,187 - Market Cap (intraday)
1.042B - Beta (5Y Monthly) 1.56
- PE Ratio (TTM)
39.76 - EPS (TTM)
0.76 - Earnings Date Aug 4, 2025 - Aug 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
33.00
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities in Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
pennantgroup.com7,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: PNTG
View MorePerformance Overview: PNTG
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PNTG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PNTG
View MoreValuation Measures
Market Cap
1.01B
Enterprise Value
1.34B
Trailing P/E
38.70
Forward P/E
26.04
PEG Ratio (5yr expected)
2.00
Price/Sales (ttm)
1.31
Price/Book (mrq)
3.34
Enterprise Value/Revenue
1.79
Enterprise Value/EBITDA
27.40
Financial Highlights
Profitability and Income Statement
Profit Margin
3.40%
Return on Assets (ttm)
4.00%
Return on Equity (ttm)
11.41%
Revenue (ttm)
748.17M
Net Income Avi to Common (ttm)
25.43M
Diluted EPS (ttm)
0.76
Balance Sheet and Cash Flow
Total Cash (mrq)
5.22M
Total Debt/Equity (mrq)
105.10%
Levered Free Cash Flow (ttm)
4.89M